Technical Analysis for THRD - Third Harmonic Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| B | 12.30 | 4.33% | 0.51 |
THRD closed down 1.17 percent on Wednesday, May 8, 2024, on 65 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Up | Up |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bollinger Band Squeeze | Range Contraction | 4.33% | |
| Stochastic Reached Overbought | Strength | 4.33% | |
| Outside Day | Range Expansion | 4.33% | |
| Overbought Stochastic | Strength | 4.33% | |
| MACD Bullish Signal Line Cross | Bullish | 3.10% | |
| 180 Bullish Setup | Bullish Swing Setup | 3.10% | |
| Bollinger Band Squeeze | Range Contraction | 3.10% | |
| Narrow Range Bar | Range Contraction | 3.10% | |
| Up 3 Days in a Row | Strength | 3.10% | |
| Up 4 Days in a Row | Strength | 3.10% |
| Alert | Time |
|---|---|
| Upper Bollinger Band Resistance | about 3 hours ago |
| 60 Minute Opening Range Breakout | about 3 hours ago |
| Rose Above Previous Day's High | about 3 hours ago |
| Rose Above Upper Bollinger Band | about 3 hours ago |
| Up 3% | about 3 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Mast Cell Chronic Urticaria Immunoglobulin E
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Organ Systems Allergy Type I Hypersensitivity Mast Cell Chronic Urticaria Immunoglobulin E
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 12.42 |
| 52 Week Low | 4.31 |
| Average Volume | 161,741 |
| 200-Day Moving Average | 8.54 |
| 50-Day Moving Average | 10.41 |
| 20-Day Moving Average | 11.45 |
| 10-Day Moving Average | 11.37 |
| Average True Range | 0.64 |
| RSI (14) | 60.16 |
| ADX | 19.91 |
| +DI | 22.26 |
| -DI | 16.92 |
| Chandelier Exit (Long, 3 ATRs) | 10.50 |
| Chandelier Exit (Short, 3 ATRs) | 12.00 |
| Upper Bollinger Bands | 12.20 |
| Lower Bollinger Band | 10.70 |
| Percent B (%b) | 0.73 |
| BandWidth | 13.06 |
| MACD Line | 0.37 |
| MACD Signal Line | 0.36 |
| MACD Histogram | 0.0074 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 12.60 | ||||
| Resistance 3 (R3) | 12.59 | 12.32 | 12.47 | ||
| Resistance 2 (R2) | 12.32 | 12.11 | 12.32 | 12.42 | |
| Resistance 1 (R1) | 12.05 | 11.98 | 11.92 | 12.06 | 12.37 |
| Pivot Point | 11.78 | 11.78 | 11.71 | 11.78 | 11.78 |
| Support 1 (S1) | 11.51 | 11.57 | 11.38 | 11.52 | 11.21 |
| Support 2 (S2) | 11.24 | 11.44 | 11.24 | 11.16 | |
| Support 3 (S3) | 10.97 | 11.24 | 11.12 | ||
| Support 4 (S4) | 10.98 |
